Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 8, 2024Journal of Heterocyclic Chemistry

Fused Thiazolo2,3‐bQuinazolinone–Chromone Hybrids: Synthesis, Characterization, In Vitro Antibacterial Activity and In Silico Screening

View Full Paper
Ask AI
Bookmark
Share

Authors

RGRajitha GaliJBJanardhan BanothuPSPunam Salaria

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gali et al. (2024) studied this question.

synapsesocial.com/papers/68e590f7b6db64358752ca59https://doi.org/10.1002/jhet.4892
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Exploring novel thiazolo[5,4-f]quinoline-based scaffolds as promising antimicrobial agents through synthesis and molecular insights2025 · 5 citations
  2. 2Synthesis, Antimicrobial Activity, and Molecular Docking Studies of New Quinoxaline‐Heterocycle Hybrids2026 · 3 citations
  3. 3Synthesis of Novel 2-Quinolone linked 1,2,3-Triazole Derivatives as Potent Antimicrobial Activities: in silico Docking Studies2024
  4. 4Design, Synthesis, and Evaluation of Quinoline‐1,2,3‐Triazole Hybrids as CYP51 Inhibitors: <i>In Silico</i> Study and <i>In Vitro</i> Antimicrobial Assessment2024 · 11 citations
  5. 5Synthesis, Biological Properties, and Molecular Docking Study of Novel 1,2,3-Triazole-8-quinolinol Hybrids2024 · 47 citations